Recon: FDA approves Cytokinetics’ heart drug in first for drugmaker; Shionogi forges $2.5 billion buyout of Tanabe Pharma’s ALS therapy Radicava
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeMedical DevicesPharmaceuticalsUnited StatesReconJason ScottBiologics/ biosimilars/ vaccinesEuropeMedical DevicesPharmaceuticalsUnited States